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The major canalicular bile salt export pump (Bsep) of
mammalian liver is downregulated by endotoxin. This
study reports on the effects of dexamethasone and
osmolarity on Bsep mRNA expression in cultured rat
hepatocytes and its functional relevance in rat liver.
Expression of Bsep mRNA in rat hepatocytes 24 and
48h after isolation was dependent on the presence of
dexamethasone (100nM) in the culture medium. Bsep
was functionally active at the pseudocanalicular
membrane in cells cultured for 4 days in medium con-
taining dexamethasone. Hypoosmolarity (205 mosmol/l)
led to an induction of Bsep mRNA levels, whereas
expression was decreased by hyperosmolarity (405
mosmol/l). Also the decay of Bsep mRNA following
dexamethasone withdrawal was osmosensitive. In
rat liver, dexamethasone counteracted the lipopoly-
saccharide (LPS)-induced down-regulation of Bsep
mRNA levels after 12 hours and abolished the LPS-in-
duced inhibition of taurocholate excretion. These re-
sults indicate that glucocorticoids are strong inducers
of Bsep in liver. Furthermore, Bsep mRNA levels are
osmosensitively regulated. The data suggest a long-
term control of Bsep mRNA by osmolarity in addition
to the short-term effects on canalicular bile acid ex-
cretion, which were reported recently.
Key words: ABC-transporter / Cell volume /
Cholestasis / Glucocorticoids / Taurocholate excretion.
Introduction
Canalicular excretion in the liver is a regulated, ATP-de-
pendent process and requires the coordinated action of a
number of ATP-binding cassette (ABC) transporter pro-
teins in the sinusoidal and canalicular domains of the he-
patocyte (Muller et al., 1997). One important member is
the canalicular bile salt export pump (Bsep), which is high-
ly related to the P-glycoprotein (Pgp) family and has previ-
ously been called sister of P-glycoprotein (Childs et al.,
1995; Gerloff et al., 1998; Strautnieks et al., 1998). Bsep is
a 170 kDa glycosylated protein in the canalicular mem-
brane and its full-length cDNA was isolated from rat
(Gerloff et al., 1998). Tissue distribution revealed predom-
inant expression of Bsep in the liver, where it was localized
to the canalicular microvilli and to subcanalicular vesicles
of the hepatocytes (Gerloff et al., 1998). The expression of
Bsep is correlated with the differentiation of hepatocytes
and is seen only in late liver development (Childs et al.,
1998). Furthermore, Bsep-mediated transport rates of
various bile salts followed the same order of magnitude as
ATP-dependent transport in canalicular rat liver plasma
membrane vesicles, i. e. taurochenodeoxycholate 
tauroursodeoxycholate = taurocholate  glycocholate
(Gerloff et al., 1998). Hypoosmotic perfusion of the isolat-
ed rat liver stimulated taurocholate excretion into bile
(Häussinger et al., 1992, 1993; Noé et al., 1996). Mutations
in the BSEP gene are found in a subgroup of patients with
progressive familial intrahepatic cholestasis (PFIC)
(Strautnieks et al., 1998). 
Endotoxin-induced cholestasis is mainly caused by an
impaired canalicular secretion, i. e. by decreased Bsep
and canalicular multispecific organic anion transporter
(MRP2) levels, as well as an abnormal localization of these
proteins (Trauner et al., 1997; Vos et al., 1998; Kubitz et al.,
1999a). MRP2 is also regulated on a short-term basis by
an osmodependent insertion/retrieval of carrier molecules
into/from the canalicular membrane (Kubitz et al., 1997).
Recently it was shown that MRP2 expression is regulated
by osmolarity and dexamethasone in primary rat hepato-
cytes (Kubitz et al., 1999b). Further, cholestasis induced
by endotoxin is counteracted by glucocorticoids (Roelof-
sen et al., 1995; Kubitz et al., 1999a). We therefore studied




Expression of Bsep mRNA in Cultured
Rat Hepatocytes
Hepatocytes were grown for 12 hours in normoosmotic
Dulbecco’s modified eagle medium (DMEM, 305 mosmol/l)
without (control) or with 100nM dexamethasone or insulin.
Thereafter they were exposed to anisoosmotic medium
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(i. e. DMEM with appropriately reduced or increased NaCl
concentration) with the same supplements for 9 hours. As
shown in Figure 1, Bsep mRNA expression was depen-
dent on the presence of 100nM dexamethasone and on
osmolarity of the culture medium in primary rat hepato-
cytes. 
When Bsep mRNA levels were standardized to glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) mRNA
there was a 10-fold difference in cells grown with 100nM
or without dexamethasone. Addition of 100nM insulin
without dexamethasone had no effect on Bsep mRNA lev-
els (Figure 1). In line with a previous study (Kubitz et al.,
1999b), MRP2 mRNA was only detectable when dexam-
ethasone was present (Figure 1). 
Furthermore, hepatocytes cultured in the presence of
dexamethasone for 4 days showed a strong staining of
Bsep at the pseudocanalicular membranes as demon-
strated by immunocytochemical staining (Figure 2A).
Compared to Bsep, a similar localized expression of
rat liver cell-cell adhesion molecule (C-CAM), another
canalicular protein (Lucka et al., 1995), was detected in the
hepatocytes under these conditions (Figure 2B). The func-
tional activity of Bsep was shown by a filling of the pseudo-
Fig.2 Bsep Expression in Rat Hepatocytes Cultured with Dexa-
methasone.
(A), (B): Freshly isolated rat hepatocytes were cultured in DMEM
supplemented with 10% FBS, 100nM dexamethasone, 100nM in-
sulin, 1g/ml aprotinin and 30nM sodium selenite for 4 days.
Pseudocanalicular immunoreactivity for Bsep (A) and for cell-cell
adhesion molecule (C-CAM) (B) is found in these cells (see ar-
rows). Dexamethasone-treated hepatocytes showed 15 minutes
after addition of cholyllysylfluorescein (2M) an accumulation of
this Bsep substrate in the pseudocanalikuli (see arrows), indicat-
ing that Bsep is functionally active under this condition (C).
Bars = 50 m.
Fig.1 Regulation of Bsep mRNA in Rat Hepatocytes by Dex-
amethasone and Osmolarity.
Rat hepatocytes were cultured for 12 hours in DMEM (305
mosmol/l; with 10% FBS, 100nM dexamethasone or insulin), then
the medium was changed to hypo- (205 mosmol/l), normo- (305
mosmol/l) or hyperosmotic (405 mosmol/l) DMEM with the same
supplements. RNA was isolated after 9 hours and analyzed by
Northern blotting. Dexamethasone and hypoosmotic medium in-
creased Bsep mRNA levels, whereas addition of insulin (100nM)
without dexamethasone had no effect on Bsep mRNA levels. In
contrast to Bsep, MRP2 mRNA was only detectable when dex-
amethasone was present (Kubitz et al., 1999b). GAPDH mRNA
was used as standard. Data are representative of 3 different ex-
periments for each condition.
Fig.3 Time Course of Regulation of Bsep mRNA Levels in Rat
Hepatocytes by Osmolarity.
Rat hepatocytes were cultured for 12 hours in DMEM (305
mosmol/l; with 10% FBS, 100nM dexamethasone, 100nM insulin,
1g/ml aprotinin and 30nM sodium selenite), then the medium
was changed to hypo- (205 mosmol/l), normo- (305 mosmol/l) or
hyperosmotic (405 mosmol/l) DMEM with the same supplements.
RNA was isolated at the time points indicated and analyzed by
Northern blots. Bsep mRNA levels were standardized by GAPDH
mRNA and the relative Bsep mRNA levels found in normoosmot-
ic incubations at each time point were set to 100% and the rela-
tive Bsep mRNA levels found in hypoosmotic () or hyperosmotic
media () were expressed as percentages of controls. Hypoos-
motic medium increased Bsep mRNA levels after 6 hours, where-
as hyperosmotic incubation significantly decreased Bsep mRNA
levels after 9 hours compared to normoosmotic control. Data are
given as mean  SEM and are from 3–4 independent hepato-
cyte preparations. * Significantly different from the normoosmotic
incubations.
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canaliculi with cholyllysylfluorescein (Figure 2C), which is
a fluorescent Bsep substrate (Mills et al., 1997).
Compared to a normoosmotic control, expression of
Bsep mRNA was increased under hypoosmotic condi-
tions (i. e. when cells were exposed to medium of 205
mosmol/l) and reduced when they were kept in hyperos-
motic (405 mosmol/l) medium. In contrast to MRP2, hy-
poosmolarity effects on Bsep mRNA levels were already
seen in the absence of dexamethasone (Figure 1). Thus,
osmolarity probably modifies Bsep expression in a dex-
amethasone-independent way.
When the cells were grown in DMEM supplemented
with 10% fetal bovine serum (FBS), 100nM dexametha-
sone, 100nM insulin, 1 g/ml aprotinin and 30nM sodium
selenite, induction of Bsep mRNA levels by hypoosmolar-
ity was already observed after 6 hours of anisoosmolarity,
whereas hyperosmotic incubation significantly decreased
Bsep mRNA levels after 9 hours compared to the nor-
moosmotic control (Figure 3). After 48 hours anisoosmot-
ic exposure, hypoosmolarity (205 mosmol/l) increased the
relative amount of Bsep mRNA (standardized with
GAPDH) by 146  53%, whereas hyperosmolarity (405
mosmol/l) decreased it by 44  11%, compared to nor-
moosmotic incubations (mean  SEM, n = 3 prepara-
tions). 
In order to exclude the possibility that differences in
dexamethasone-dependent Bsep mRNA levels were due
to effects of dexamethasone on cell growth, hepatic
parenchymal cells were cultured for 36 hours in DMEM
supplemented with 10% FBS, 100nM dexamethasone,
100nM insulin, 1 g/ml aprotinin and 30nM sodium selen-
ite until they reached confluence. When Bsep mRNA
levels at this time point were set to 100% (= control level),
expression was not significantly altered 36 hours later
(90  24% of control level, n = 4) but reduced to 63  32%
(n = 3) after 48 hours. Upon lowering the dexamethasone
concentration or its withdrawal Bsep mRNA levels strong-
ly declined already within 24 hours, compared to the incu-
bations with 100nM dexamethasone (Figure 4). 
The effect of anisotonicity on Bsep mRNA expression
also occurred when hepatic parenchymal cells were cul-
tured for 36 hours under this condition (Figure 5). Hypoos-
molarity also diminished the decline of Bsep levels follow-
ing dexamethasone-withdrawal (Figure 5). These results
suggest that the osmo-dependent Bsep expression may
be regulated at least in part pretranslationally. 
Effect of Dexamethasone on LPS-Induced
Decrease in Bsep mRNA Levels and its Function in
Perfused Rat Liver
In line with Vos et al. (1998), lipopolysaccharide (LPS)
treatment led to a down-regulation of Bsep mRNA levels
after 12 hours in rat liver, whereas Bsep mRNA levels were
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Fig.4 Bsep mRNA Level Decreases after Withdrawal of Dexa-
methasone in Rat Hepatocytes.
Rat hepatocytes were cultured for 36 hours in DMEM (305
mosmol/l; with FBS, 100nM dexamethasone, 100nM insulin, 1g/
ml aprotinin and 30nM sodium selenite), then the medium was
changed to DMEM with 0, 1 or 100nM dexamethasone. RNA was
isolated 24 to 48 hours later and analyzed by Northern blotting.
While relative Bsep mRNA levels in cells cultured in the presence
of 100nM dexamethasone remained relatively unchanged, a con-
tinuous decline of Bsep mRNA was observed when dexametha-
sone was displaced (A). Reduction of the relative amount of
Bsep mRNA (B). The Bsep mRNA levels found in incubations with
100nM dexamethasone at each time point were set to 100% ()
and the relative Bsep mRNA levels found in media with 1nM ()
or without () dexamethasone were expressed in relation to the
dexamethasone controls. Data are given as mean  SEM and
are from 3 independent hepatocyte preparations. * Significantly
different from the incubations with 100nM dexamethasone.
Fig.5 Osmosensitive Regulation of Bsep mRNA Levels after
Withdrawal of Dexamethasone in Rat Hepatocytes.
Rat hepatocytes were cultured for 36 hours in DMEM (305
mosmol/l; with 10% FBS, 100nM dexamethasone, 100nM insulin,
1g/ml aprotinin and 30nM sodium selenite), then the medium
was changed to hypo- (205 mosmol/l), normo- (305 mosmol/l) or
hyperosmotic (405 mosmol/l) DMEM with 0, 1 or 100nM dexam-
ethasone and supplements as given above. RNA was isolated
24 hours later and analyzed by Northern blots. GAPDH mRNA
was used as standard. Data are representative of 3 different ex-
periments for each condition.
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largely unaffected during the first 6 hours after LPS treat-
ment (Figure 6). Interestingly, dexamethasone partially
restored the Bsep and MRP2 mRNA signals (Figure 6,
Table 1). 
Livers from rats that received an IP injection of LPS
(4 mg/kg body wt), saline (control) or LPS plus dexam-
ethasone (1 mg/kg body wt) 3, 6, or 12 hours before the
liver perfusion were perfused in a nonrecirculating way
with a medium containing [3H]-taurocholate (100 M). The
steady-state taurocholate excretion into bile and bile flow
were monitored by determination of [3H]-excretion into
bile. LPS treatment decreased taurocholate excretion into
bile by 30  22%, 56  9%, and 59  8% after 3, 6, and 12
hours, respectively ( SEM, n = 4). As shown in Table 1,
LPS also reduced basal bile flow and bile flow in the pres-
ence of taurocholate 12 hours after injection. Dexametha-
sone counteracted the LPS-induced decrease in biliary
excretion of taurocholate and bile flow (Figure 7, Table 1). 
Discussion
This study demonstrates that dexamethasone and osmo-
larity regulate the expression of Bsep at the mRNA level in
cultured rat hepatocytes. This was observed during early
culture as well as in confluent cells (i. e. after 36 hours of
culture), suggesting that dexamethasone and hypoosmo-
larity not only stimulate Bsep mRNA expression in prolifer-
ating cells but also maintain a high Bsep mRNA level in
confluent cells. As shown in Figure 2, Bsep protein was still
present in the pseudocanalicular membrane of hepato-
cytes after 4 days of culture in medium containing dexam-
ethasone, and functional activity of Bsep is suggested by
filling of the pseudocanaliculi with cholyllysylfluorescein,
which is a Bsep substrate (Mills et al., 1997).
Endotoxin-induced cholestasis is probably mainly
caused by decreased levels of Bsep and the canalicular
multispecific organic anion transporter MRP2, as well as
an abnormal localization of these proteins (Vos et al., 1998;
Kubitz et al., 1999a). Bsep and MRP2 are strongly down-
regulated in this situation, and canalicular bile salt secre-
Table1 Effect of Dexamethasone on LPS-Induced Decrease in Biliary Excretion of Taurocholate and Bile Flow in Rat Liver.
Control LPS LPS+Dex
Taurocholate excretion in bile (nmol/g/min) 204.9  5.3 81.4  18.3* 178.9  16.1
Bile flow basal (l/g/min) 1.28  0.16 0.71  0.05* 1.12  0.10
Bile flow in presence of 100 M taurocholate (l/g/min) 3.26  0.16 1.93  0.36* 2.35  0.20* 
Relative Bsep mRNA levels (%) 100 42  9* 139  25
Relative MRP2 mRNA levels (%) 100 12  3* 92  22
Animals were injected IP with either saline (‘control’), LPS (4 mg/kg body wt) (‘LPS’) or LPS plus dexamethasone (1 mg/kg body wt)
(‘LPS+Dex’). The livers were used for the perfusion experiments and Northern blot analysis as described in Materials and Methods
12 hours later. In perfusion experiments, 100 M [3H]-taurocholate was added to the influent after approx. 30 minutes of perfusion. In
Northern blot analyses, GAPDH mRNA was used for standardization. The relative Bsep and MRP2 mRNA levels found in control rat liver
were set to 100%, respectively, and the relative mRNA levels found in liver from LPS or LPS plus dexamethasone treated rats were ex-
pressed as percentages thereof. LPS reduced taurocholate excretion into bile, basal bile flow, bile flow in presence of taurocholate, Bsep
and MRP2 mRNA levels. Dexamethasone counteracted the LPS-induced decrease in biliary excretion of taurocholate, bile flow and
mRNA levels. Data are given as mean  SEM and are from 4 different perfusion experiments for each condition. 
* Significantly different from the control.
Fig.6 Effect of LPS and Dexamethasone on Bsep mRNA Levels
in Rat Liver.
Animals were pretreated by IP injection of saline (control), LPS
(4 mg/kg body wt) or LPS plus dexamethasone (1 mg/kg body wt).
At the time points indicated, the livers were removed for RNA ex-
traction and Northern blot analysis. GAPDH mRNA was used as
standard. Data are representative of 3 different experiments for
each condition.
Fig.7 Dexamethasone Abolishes the LPS-Induced Inhibition of
Taurocholate Excretion in Perfused Rat Liver.
Animals were injected IP with either saline (control) (‘NaCl’), LPS
(4 mg/kg body wt) (‘LPS’) or LPS plus dexamethasone (1 mg/kg
body wt) (‘LPS+Dex’). The livers were used for the perfusion
experiment 12 hours later. LPS reduced taurocholate excretion
significantly (P  0.05, steady-state), whereas dexamethasone
counteracted this effect. Data are given as mean + SEM and are
from 4 different perfusion experiments for each condition.
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tion is also reduced. LPS induced the appearance of
MRP2 in intracellular vesicles in the immediate vicinity of
the canaliculi within 3 hours, and these vesicles were re-
mote from the canaliculi after 6 and 12 hours (Kubitz et al.,
1999a). The LPS effects on the subcellular distribution of
MRP2 and on MRP2 mRNA levels and bromosulphalein
excretion were counteracted by dexamethasone (Kubitz
et al., 1999a). As shown in Figure 6 and 7, dexamethasone
also counteracted the LPS-induced decrease in Bsep
mRNA levels and in taurocholate excretion in rat liver.
Cell swelling after hypoosmotic exposure was shown to
increase the capacity of taurocholate transport into bile
(Häussinger et al., 1992; Noé et al., 1996). The stimulation
of taurocholate excretion by hypoosmolarity involves a G
protein- and tyrosine kinase-dependent but protein ki-
nase C-independent activation of the mitogen-activated
protein kinases Erk-1 and Erk-2 in hepatocytes (Noé et al.,
1996). The osmotic regulation of bile acid secretion was
suggested to involve the level of a dynamic equilibrium be-
tween transporter insertion into and transporter retrieval
from the canalicular membrane (Häussinger et al., 1992,
1993) as shown morphologically for MRP2 (Kubitz et al.,
1997, 1999a). Further, changes of the ambient osmolarity
regulate MRP2 activity on a short-term time scale by car-
rier retrieval/insertion from/into the canalicular membrane
and by long-term effects at the level of MRP2 mRNA ex-
pression (Kubitz et al., 1997, 1999b). These long-term ef-
fects on MRP2 mRNA levels were dexamethasone-de-
pendent in rat hepatocytes (Kubitz et al., 1999b). However,
hypoosmolarity in the absence of dexamethasone was
able to induce Bsep mRNA (compare Figure 1), suggestive
of dexamethasone-independent osmodependent regula-
tion of Bsep expression. Although several osmosignalling
pathways have been characterized in liver (Schliess et al.,
1995; Noé et al., 1996; Häussinger et al., 1997), further




Dulbecco’s modified eagle medium (DMEM, with or without
NaCl), fetal bovine serum (FBS) and penicillin/streptomycin were
purchased from Biochrom (Berlin, Germany). Dexamethasone
was from Merck (Darmstadt, Germany) and [-32P]dCTP (3000
Ci/mmol) from ICN (Meckenheim, Germany). Insulin (bovine pan-
creas) and lipopolysaccharide (LPS) from Salmonella typhimuri-
um were from Sigma (Deisenhofen, Germany). The 347 bp cDNA-
probe for the rat MRP2 (Büchler et al., 1996) was a gift from Dr. D.
Keppler (Heidelberg, Germany). The 1.0 kb cDNA fragment of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which
was used for standardization, was from Clontech (Palo Alto,
USA). The polyclonal antibody against Bsep was raised in a rab-
bit against the C-terminal amino acids of the rat Bsep sequence
(Gerloff et al., 1998). The mouse monoclonal antibody Be-9.2 was
raised against the rat cell-cell adhesion molecule (C-CAM) (Lucka
et al., 1995) and was a generous gift from Dr. W. Reutter (Berlin,
Germany). Cy3TM-conjugated AffiniPure goat anti-rabbit IgG and
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fluorescein-conjugated AffiniPure goat anti-mouse IgG were from
Jackson ImmunoResearch Laboratories (West Grove, PA, USA).
The Bsep substrate cholyllysylfluorescein (Mills et al., 1997) was
a generous gift from Dr. C.O. Mills (Birmingham, United Kingdom). 
Isolation and Culture of Rat Hepatocytes 
Isolated rat hepatocytes were prepared from livers of male Wistar
rats (150–180g, fed ad libitum) by collagenase perfusion as de-
scribed previously (Noé et al., 1996). Cell viability was more than
90% as assessed by trypan blue exclusion. Cell purity 24 hours
after isolation was approx. 99% as assessed by morphological
examination. Hepatocytes were seeded in a density of 0.1  106
cells/cm2 on collagen type VII coated 6-well plates (Becton-Dick-
inson, Heidelberg, Germany). They were cultured in Dulbecco’s
modified eagle medium (DMEM) containing glucose (6 mM),
penicillin (100 U/ml) and streptomycin (100 g/ml). In some ex-
periments the medium was supplemented with 10% FBS, dex-
amethasone (100 nM), insulin (100 nM), aprotinin (1 g/ml) and
sodium selenite (30 nM), according to the protocols described
in the Results part. Furthermore, in some experiments cells were
exposed to hypoosmotic (205 mosmol/l) or hyperosmotic (405
mosmol/l) medium. Osmolarity was changed by appropriately
altered NaCl concentration of the DMEM. 
Northern Blot Analysis 
Total RNA from culture plates of liver parenchymal cells in cluster
6 dishes (Costar, Cambridge, USA) was isolated by using a total
RNA extraction kit (Qiagen, Hilden, Germany). Liver tissues were
isolated from Wistar rats and about 1 g of tissue was immediately
homogenized in 10 ml of guanidinium isothiocyanate solution on
ice with an Ultra-Turrax instrument at high speed. Thereafter, total
RNA was isolated as in (Chomczynski and Sacchi, 1987). RNA
samples were electrophoresed in 0.8% agarose/3% formalde-
hyde gels and then blotted onto Duralon-UV nylon membranes
(Stratagene, Heidelberg, Germany) with 20  SSC (3 M NaCl, 0.3 M
sodium citrate). Following blotting the membranes were UV-
crosslinked (Hoefer UV-crosslinker 500, Hoefer, San Francisco,
USA) and observed under UV illumination to determine RNA in-
tegrity and the 28S and 18S rRNA bands. Hybridization was car-
ried out with approximately 106 cpm/ml [-32P]dCTP-labelled
Bsep (Gerloff et al., 1998), MRP2 (Büchler et al., 1996) or GAPDH
cDNA probes as described in (Warskulat et al., 1997). The probes
were labelled by random priming under the conditions recom-
mended by the supplier (Pharmacia, Freiburg, Germany). Suitably
exposed autoradiograms were then analyzed with densitometry
scanning (E.A.S.Y. RH-System, Herolab, Wiesloch, Germany) to
determine the optical densities of the mRNA signals. Relative
mRNA levels were determined by standardization of the optical
density of GAPDH mRNA.
Immunocytochemistry 
For immunocytochemistry cells cultured on glass coverslips were
fixed with pure methanol (–20°C, 10 min). They were permeabi-
lized with Triton-X 100 (0.1% in PBS, 10 min) and then washed
with PBS. Unspecific binding was blocked with BSA (1% in PBS,
1 h). Either a mixture of the primary antibodies (i.e. anti-rat BSEP,
1:200 plus anti-C-CAM, 1:200), PBS alone, or a single primary
antibody for control staining were applied for 2 hours of incuba-
tion in a wet chamber. After rinsing and washing, a combination of
CY3TM-conjugated goat anti-rabbit IgG (1:500) plus FITC-conju-
gated goat anti-mouse IgG (1:100) was applied for 2 h. Finally, the
cells were washed and mounted on slides. 
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Confocal Laser Scanning Microscopy
Immunostained cell-samples were analyzed using a Leica TCS-
NT confocal laser scanning system with an argon-krypton laser
on a Leica DM IRB inverted microscope (Bensheim, Germany).
Images were acquired from two channels at 488 nm and 568 nm
wavelength. 
Evidence of Functional Bsep in Rat Hepatocytes
The transport activity of Bsep in cultured hepatocytes was as-
sessed by the use of cholyllysylfluorescein (CLF), which is a sub-
strate for Bsep and a useful probe for the intracellular visualization
of bile salt movement (Mills et al., 1997). 
Cultured hepatocytes were grown on glass coverslips in
DMEM supplemented with 10% FBS, 100nM dexamethasone,
100nM insulin, 1g/ml aprotinin and 30nM sodium selenite for 4
days and then incubated with Krebs-Henseleit Buffer (KHB) at
37°C and 5% CO2 for 1 hour before measurement. Thereafter the
coverslips were placed in a bath holder, covered with 200 l KHB
and mounted on the inverted microscope of the confocal laser
scanning system. After adjustment of the optical plane, CLF (dis-
solved in KHB) was added to the bath resulting in a final concen-
tration of 2M CLF. Cells were scanned every 5 minutes for 30
minutes (488 nm exciting light, emission measured at wave-
lengths  515 nm) with constant adjustments.
Rat Liver Perfusion 
The experiments were approved by the responsible local author-
ities. Male Wistar rats (120–150 g) with free access to stock diet
were injected intraperitoneally (IP) with saline (control) or LPS
(4 mg/kg body wt) 3, 6, or 12 hours before the experiments or with
LPS plus dexamethasone (1 mg/kg body wt) 12 hours before the
experiments. Livers of injected animals were perfused in situ in
a nonrecirculating system with Krebs-Henseleit buffer (305
mosmol/l) at 37°C, equilibrated with 5%/95% (vol/vol) CO2/O2
and supplemented with 0.3mM pyruvate and 2.1mM lactate as
described previously (Häussinger et al., 1992, 1993; Noé et al.,
1996). Perfusate flow was approximately 4 ml/g liver and was kept
constant throughout the individual experiment. Potassium and
pH were monitored continuously with electrodes (Radiometer,
Copenhagen, Denmark). Portal pressure was recorded using a
pressure transducer (Hugo Sachs Electronics, March, Germany).
Liver viability was assessed from the measurements of K+-efflux
and of portal pressure. [3H]-taurocholate (100M) was added to
the influent after approx. 30 minutes of perfusion. Bile ducts were
cannulated and samples were collected every 4 minutes. [3H]-
taurocholate in bile was measured by scintillation spectrometry
as described previously (Häussinger et al., 1992). 
Statistics 
Data were reproduced in at least 3 independent hepatocyte
preparations or liver perfusion experiments. Values are ex-
pressed as means  SEM. Statistical analysis was performed
using Student’s t-Test. P values of  0.05 were considered to be
statistically significant.
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